Results 91 to 100 of about 210,635 (269)

Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome

Gynecology Obstetrics & Reproductive Medicine, 2013
OBJECTIVE: The purpose of the present study is to compare the use of GnRH antagonist salvage versus coasting for the prevention of OHSS in patients undergoing IVF/ICSI cycles with long GnRH agonist protocol. STUDY DESIGN: Medical records of 91 patients (
Cavidan Gülerman, Nafiye Yılmaz, Ayla Sargın Oruç, Nazlı Özkan, Ayten Türkkanı, Esma Sarıkaya, Okan Yenicesu   +6 more
doaj  

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis

Journal of Advanced Research, 2015
Final oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with HCG or a GnRH agonist. We conducted a systematic review and meta-analysis of randomized controlled trials to evaluate the efficacy and safety of the final oocyte ...
M.A.F. Youssef, Hatem I. Abdelmoty, Mohamed A.S. Ahmed, Maged Elmohamady   +3 more
doaj   +1 more source

Triple-Negative Breast Cancers Express Receptors for GnRH and Can Be Effectively Targeted by the Orally Active GnRH-Antagonist AEZS 115.

, 2009
IntroductionAEZS-115* is an orally active peptidomimetic antagonist of GnRH, which has been shown to block the pituitary GnRH receptor. In various tumors an autocrine growth promoting loop consisting of GnRH secreted by the malignant cells and tumoral ...
U. Kämmerer, A. Honig, S. Seitz, T. Gaiser, A. Schreiber, J. Engel, F. Köster, J. Dietl   +7 more
core   +1 more source

Reproductive Challenges of the Ageing Female: A Comprehensive Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Changes in societal norms over the last few decades have resulted in novel family planning trends, notably delayed childbearing and increased maternal age at the birth of the first child. Despite advances in reproductive medicine, ageing poses significant challenges.
Sofia Bitzika, Meletios P. Nigdelis, Angelos Daniilidis, Erich‐Franz Solomayer, Irene Lambrinoudaki, Efstratios M. Kolibianakis, Dimitrios G. Goulis   +6 more
wiley   +1 more source

Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas, Olivia Carere, Lauren Clarfield, Michelle Jacobson   +3 more
wiley   +1 more source

Table_1_Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium.docx

, 2023
ObjectiveTo compare the pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium.MethodsThis retrospective study included all fresh embryo transfers following GnRH agonist or GnRH ...
Xuemei Li (232384), Rui Xie (826938), Depeng Zhao (1608115)   +2 more
core   +1 more source

Effect of Salinity Stress on Gut–Brain–Gonad Axis in the Red‐Eared Slider (Trachemys scripta elegans)

Integrative Zoology, EarlyView.
The increase in salinity leads to changes in the gut microbiota and metabolites of Trachemys scripta elegans, affecting the synthesis and secretion of neurotransmitters or precursors, which can inhibit the secretion of reproductive hormones and affect the self‐renewal and differentiation process of spermatogonial stem cells.
Qiongyu Zhang, Na Li, Xue Tang, Hanru Chen, Meiling Hong, Li Ding   +5 more
wiley   +1 more source

Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study [PDF]

, 2009
This study was designed to evaluate the effect of luteal-phase administration of single-dose gonadotrophin-releasing hormone (GnRH) agonist on pregnancy, implantation and live birth rates in patients who received GnRH antagonist for pituitary ...
Vicdan, Kubilay, Işık, Zeki, Çağlar, Gamze Sinem, Sözen, Eran, Akarsu, Cem, Özbiçer, Tülay, Tuncay, Görkem, A.Z. Isik, E. Sozen, T. Ozbıcer, C. Akarsu, G. Tuncay, G.S. Caglar, K. Vicdan   +13 more
core   +1 more source

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski, Rachel Dear, Sanjeev Kumar, Hilary Martin, Dhanusha Sabanathan, Stephen J. Luen, Belinda Yeo   +6 more
wiley   +1 more source

Progestin-Primed Ovarian Stimulation versus GnRH Antagonist Protocol for Ovarian Stimulation in IVF: A Prospective Pilot Study

Fertility & Reproduction
Background: Progestin-primed ovarian stimulation (PPOS) has been proposed as an alternative to conventional gonadotropin-releasing hormone (GnRH) antagonist protocol for ovarian stimulation in in vitro fertilization (IVF).
Tien K. Le, Xuyen H. Le, Duy L. Nguyen, Anh L. Vu, Lan N. Vuong   +4 more
doaj   +1 more source